Center for Pediatric Inflammatory Bowel Disease

Abstracts

2006

Hommel KA, Davis C, Baldassano RN. Multimethod assessment of medical adherence in pediatric inflammatory bowel disease. National Conference on Child Health Psychology, Gainesville, FL, April 19, 2006 (poster).

Xanthopoulos MS, Nezu AM, Nezu CM, Barakat LP, Markowitz JE, Baldassano RN. The relationship between disease activity severity and psychosocial factors in adolescents diagnosed with Crohn’s disease. National Conference on Child Health Psychology, Gainesville, FL, April 19, 2006 (poster).

Veereman-Wauters G, Hyams J, Griffiths A, Olson A, Liu G, Heuschkel R, Baldassano RN. Maintenance therapy with infliximab every 8 weeks is superior to every 12 weeks in maintaining response and remission in pediatric patients with moderately to severely active Crohn’s disease. ESPGHAN, 39th Annual Meeting, Dresden, Germany, June 7-10, 2006; Journal of Pediatric Gastroenterology and Nutrition.

Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J, Liu G, Travers S, Heuschkel R, Markowitz J, Cohen S, Winter H, Veereman-Wauters G, Ferry G, Baldassano RN. Maintenance therapy with infliximab every 8 weeks is superior to every 12 weeks in maintaining response and remission in pediatric patients with moderately to severely active Crohn’s disease. Digestive Disease Week and the 107th Annual Meeting of the American Gastroenterological Association Institute, Los Angeles, CA; Gastroenterology, 130(4);S2,A-12, 2006.

Griffiths A, Hyams J, Crandall W, Kugathasan S, Olson A, Johanns J, Liu G, Raychaudhuri A, Travers S, Heuschkel R, Markowitz J, Cohn S, Winter H, Veereman-Wauters G, Ferry G, Baldassano RN. Height of growth delayed children with active Crohn’s disease improves during treatment with infliximab. Digestive Disease Week and the 107th Annual Meeting of the American Gastroenterological Association Institute, Los Angeles, CA; Gastroenterology, 130(4);S2,A-12, 2006.

Pfefferkorn MD, Hyams J, Burke G, Markowitz J, Rosh J, Mack D, Otley A, Kugathasan S, Evans J, Bousvaros A, Moyer S, Rothbaum R, Wyllie R, Tolia V, Oliva-Hemker M, Mezoff A, Leleiko N, Del Rosario, F, Crandall W, Keljo D, Baldassano RN, Griffiths A. Growth failure persists despite current treatment paradigms in pediatric Crohn’s disease. Digestive Disease Week and the 107th Annual Meeting of the American Gastroenterological Association Institute, Los Angeles, CA; Gastroenterology, 130(4);S2,A-191, 2006.

Rosh JR, Hyams J, Lerer T, Markowitz J, Pfefferkorn M, Mack D, Otley A, Kugathasan S, Evans J, Bousvaros A, Moyer S, Rothbaum R, Wyllie R, Tolia V, Oliva-Hemker M, Mezoff A, Leleiko N, Delrosario F, Crandall W, Keljo D, Baldassano RN, Griffiths A. Outcome of moderate to severe pediatric Crohn’s disease: Effect of infliximab therapy. Digestive Disease Week and the 107th Annual Meeting of the American Gastroenterological Association Institute, Los Angeles, CA; Gastroenterology, 130(4);S2,A-192, 2006.

Gupta N, Heyman MB, Bostrom AG, Abramson O, Kirschner BS, Winter HS, Gold BD, Ferry GD, Cohen SA, Baldassano RN. Age at diagnosis and disease course in pediatric Crohn’s disease. Digestive Disease Week and the 107th Annual Meeting of the American Gastroenterological Association Institute, Los Angeles, CA; Gastroenterology, 130(4);S2,A-218, 2006.

Gupta N, Heyman MB, Bostrom AG, Ferry GD, Cohen SA, Baldassano RN, Abramson O, Kirschner BS, Winter HS, Gold BD. Age at diagnosis and presentation of pediatric Crohn’s disease. Digestive Disease Week and the 107th Annual Meeting of the American Gastroenterological Association Institute, Los Angeles, CA; Gastroenterology, 130(4);S2,A-219, 2006.

Thayu M, Baldassano RN, Zemel BS, Hollis BW, Leonard MB. Vitamin D deficiency is associated with deficits in trabecular and cortical bone in incident pediatric Crohn’s disease. Digestive Disease Week and the 107th Annual Meeting of the American Gastroenterological Association Institute, Los Angeles, CA; Gastroenterology, 130(4);S2,A-646, 2006.

Colletti RB, Baldassano RN, Milov DE, Margolis PA, PIBDNET Pediatric IBD Network for Research and Improvement. Variation in initial 6-mercaptopurine dosage in pediatric Crohn’s disease. Digestive Disease Week and the 107th Annual Meeting of the American Gastroenterological Association Institute, Los Angeles, CA; Gastroenterology, 130(4);S2,A-652, 2006.

Thayu M, Leonard M, Hyams J, Crandall W, Kugathasan S, Otley A, Olson A, Liu G, Marano C, Heuschkel R, Veereman-Wauters G, Griffths A, Baldassano RN, and the REACH Study Group. Improvement in a biomarker of bone formation during infliximab therapy in pediatric Crohn’s disease: Results of the REACH Study. First International Symposium on Pediatric Inflammatory Bowel Disease, Rome, Italy; Journal of Pediatric Gastroenterology and Nutrition, 43(2);S20, 2006.

Colletti RB, Baldassano RN, Milov DE, Margolis PA, for PIBDNet – the Pediatric IBD Network for Research and Improvement. Predictors of outcome of treatment of pediatric Crohn’s disease with 6-Mercaptopurine or Azathioprine. First International Symposium on Pediatric Inflammatory Bowel Disease, Rome, Italy; Journal of Pediatric Gastroenterology and Nutrition, 43(2);S40, 2006.

Colletti RB, Baldassano RN, Milov DE, Margolis PA, for PIBDNet – the Pediatric IBD Network for Research and Improvement. Initial dosage of 6-Mercaptopurine in pediatric Crohn’s disease: A study of variation in care. First International Symposium on Pediatric Inflammatory Bowel Disease, Rome, Italy; Journal of Pediatric Gastroenterology and Nutrition, 43(2);S41, 2006.

Otley AR, Hyams J, Baldassano RN, Crandall W, Kugathasan S, Xu S, Yan S, Olson A, Liu G, Veereman-Wauters G, Griffiths AM, and the REACH Study Group. The effects of infliximab therapy on health-related quality of life in pediatric Crohn’s disease. First International Symposium on Pediatric Inflammatory Bowel Disease, Rome, Italy; Journal of Pediatric Gastroenterology and Nutrition, 43(2);S48 2006.

Walters TD, Hyams J, Baldassano RN, Crandall W, Kugathasan S, Otley AR, Olson A, Xu S, Yan S, Liu G, Heuschkel R, Veereman-Wauters G, Griffths AM, and the REACH Study Group. Linear growth during infliximab therapy: Results of the REACH Multicenter Study. First International Symposium on Pediatric Inflammatory Bowel Disease, Rome, Italy; Journal of Pediatric Gastroenterology and Nutrition, 43(2);S54, 2006.

Contact Us

Contact the Center for Pediatric Inflammatory Bowel Disease.

Awards and Honors

Legal

Short Cuts

Main Number: 215-590-1000
Physician Referral Service: 1-800-879-2467
Coordinates: 39.9486937, -75.1929596
An Equal Opportunity Employer
The Children's Hospital of Philadelphia is an equal opportunity employer. We do not discriminate on the basis of race, color, gender, sexual orientation, age, religion, national or ethnic origin, disability or veteran status.